High prevalence of diabetes and pre-diabetes in adults with Williams syndrome

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 154, Issue 2, 2010, Pages 291-298

  Pober, B R ^a,b,c   Wang, E ^d   Caprio, S ^e   Petersen, K F ^e   Brandt, C ^e,f   Stanley, T ^a,c   Osborne, L R ^g   Dzuria, J ^e   Gulanski, B ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE CANCER CENTER   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes mellitus; Impaired glucose tolerance; Oral glucose tolerance test; Syntaxin 1A (STX 1A); Williams syndrome chromosome region (WSCR)

Indexed keywords

HEMOGLOBIN A1C; SYNTAXIN 1A;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE LOCATION; GENE MAPPING; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; MEDICAL PRACTICE; MORBIDITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; WILLIAMS BEUREN SYNDROME;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INSULIN; MALE; PREDIABETIC STATE; PREVALENCE; SEX CHARACTERISTICS; UNITED STATES; WILLIAMS SYNDROME;

EID: 77951588426     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30261     Document Type: Article

References (44)

1. American Academy of Pediatrics. 2001. Health care supervision for children with Williams syndrome. Pediatrics 107:1192-1204.
2. Antonell A, de Luis O, Domingo-Roura X, Perez-Jurado LA. 2005. Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23. Genome Res 15:1179-1188. (Pubitemid 41247908)
3. Anwar AJ, Walker JD, Frier BM. 1998. Type 1 diabetes mellitus and Down's syndrome: Prevalence, management, and diabetic complications. Diabet Med 15:160-163.
4. American Diabetes Association. 2004. Consensus development conference on antipsychotic drugs, obesity, and diabetes. Diabetes Care 27:596-601.
5. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovslci JA, Nelson LM, Sullivan G, Bondy CA. 2004. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516-3520. (Pubitemid 38951929)
6. Bayes M, Magano LF, Rivera N, Flores R, Perez Jurado LA. 2003. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet 73:131-151. (Pubitemid 36793786)
7. Bennett MK, Calakos N, Scheller RH. 1992. Syntaxin: A synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257:255-259.
8. Beuren AJ, Apitz J, Harmjanz D. 1962. Supravalvular aortic stenosis in association with mental retardation and a certain facial appearance. Circulation 26:1235-1240.
9. Caprio S, Boulware S, Diamond M, Sherwin RS, Caipenter TO, Rubin K, Amiel S, Press M, Tamborlanc WV. 1991. Insulin resistance: An early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72: 832-836. (Pubitemid 21921773)
10. Chan CB, MacPhail RM, Sheu L, Wheeler MB, Gaisano HY. 1999. Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes 48:997-1005. (Pubitemid 29226345)
11. Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, Schultz RT, Pober BR. 2004. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet Part A 131A:255-264.
12. Daniel S, Noda M, Straub SG, Sharp GW. 1999. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes 48: 1686-1690. (Pubitemid 29415184)
13. Gaisano HY, Ostenson CG, Sheu L, Wheeler MB, Efendic S. 2002. Abnormal expression of pancreatic islet exocytotic soluble N-ethylmaleimide-sensitive factor attachment protein receptors in Goto-Kakizaki rats is partially restored by phlorizin treatment and accentuated by high glucose treatment. Endocrinology 143:4218-4226. (Pubitemid 35239551)
14. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. 2004. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 101:7281-7286. (Pubitemid 38638024)
15. Imashuku S, Hayashi S, Kuriyama K, Hibi S, Tabata Y, Todo S. 2000. Sudden death of a 21-year-old female with Williams syndrome showing rare complications. Pediatr Int 42: 322-324. (Pubitemid 30409354)
16. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M. 2008. Six new loci associated with blood lowdensity lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197. (Pubitemid 351171402)
17. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, Gómez Pérez FJ, Frazer KA, Elliott P. Scott J, Milos PM, Cox DR. Thompson JF. 2008. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 40:149-151. (Pubitemid 351171393)
18. Lam PP, Leung YM, Sheu L, Ellis J, Tsushima RG, Osborne LR, Gaisano HY. 2005. Transgenic mouse overexpressing syntaxin-1A as a diabetes model. Diabetes 54:2744-2754. (Pubitemid 41233598)
19. Lamberta MT, Copeland LA, Sampson N, Duffy SA. 2006. New-onset type-2 diabetes associated with atypical antipsychotic medications Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:919-923.
20. Lopez-Rangel E, Maurice M, McGillivray B, Friedman JM. 1992. Williams syndrome in adults. Am J Med Genet 44:720-729.
21. Matsuda M, DeFronzo RA. 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470. (Pubitemid 29418240)
22. Merla G, Howald C, Antonarakis SE, Reymond A. 2004. The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3. Hum Mol Genet 13:1505-1514. (Pubitemid 39023058)
23. Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL. 1988. Natural history of Williams syndrome: Physical characteristics. J Pediatr 113:318-326.
24. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, Ensing GJ, Sornmer A, Moore CA, Hopkin RJ, Spallone PA, Keating MT, Osborne L, Kimberley KW, Stock AD. 2003. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: Genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet Part A 123A: 45-59. (Pubitemid 37305907)
25. Nagamatsu S, Nakamichi Y, Yamamura C, Matsushima S, Watanabe T, Ozawa S, Furukawa H, Ishida H. 1999. Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: Restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes 48: 2367-2373. (Pubitemid 30395428)
26. Nakaji A, Kawame Y, Nagai C, Iwata M. 2001. [Clinical features of a senior patient with Williams syndrome]. Rinsho Shinkeigaku 41:592-598.
27. Ohara-Imaizumi M, Fujiwara T, Nakamichi Y, Okamura T, Akimoto Y, Kawai J, Matsushima S, Kawakarni H, Watanabe T, Akagawa K, Nagamatsu S. 2007. Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis. J Cell Biol 177:695-705. (Pubitemid 46799840)
28. Osborne LR. 1999. Williams-Beuren syndrome: Unraveling the mysteries of a microdeletion disorder. Mol Genet Metab 67:1-10.
29. Osborne LR, Soder S, Shi XM, Pober B, Costa T, Scherer SW, Tsui LC. 1997. Hemizygous deletion of the syntaxin 1A gene in individuals with Williams syndrome. Am J Hum Genet 61:449-452. (Pubitemid 27382322)
30. Peoples R, Franke Y, Wang YK, Perez-Jurado L, Paperna T, Cisco M, Francke U. 2000. A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome - Deletion region at 7q11.23. Am J Hum Genet 66:47-68. (Pubitemid 30481468)
31. Phillips DI, Clark PM, Hales CN, Osmond C. 1994. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292. (Pubitemid 24144145)
32. Plissart L, Borghgraef M, Volcke P, Van den Berghe H, Fryns JP. 1994. Adults with Williams-Beuren syndrome: Evaluation of the medical, psychological and behavioral aspects. Clin Genet 46:161-167. (Pubitemid 24280201)
33. Prately RE. 1998. Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: Lessons learned from the Pima Indians. Proc Nutr Soc 57:175-181.
34. Romeo S, Sentinelli F, Cavallo MG, Leonetti F, Fallarino M, Mariotti S, Baroni MG. 2008. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: The -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. Int J Obes (Lond) 32:413-420. (Pubitemid 351414813)
35. Schuster DP, Osei K, Zipf WB. 1996. Characterization of alternations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 45:1514-1520. (Pubitemid 26424580)
36. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. 2002. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810. (Pubitemid 34984653)
37. Talebizadeh Z, Butler MG. 2004. Insulin resistance and obesity-related factors in Prader-Willi syndrome: Comparison with obese subjects. Clin Genet 67:230-239. (Pubitemid 40277903)
38. Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson SS, Durkin ME, Popescu NC, Hutton T, Metcalfe K, Rucka A, Stewart H, Read AP, Maconochie M, Donnai D. 2005. GTF2IRD1 in craniofacial development of humans and mice. Science 310:1184-1187. (Pubitemid 41681744)
39. Taylor EN, Hu FB, Curhan GC. 2006. Anti-hypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 29:1065-1070. (Pubitemid 44115245)
40. Tsunoda K, Sanke T, Nakagawa T, Furuta H, Nanjo K. 2001. Single nucleotide polymorphism (D68D, T to C) in the syntaxin 1A gene correlates to age at onset and insulin requirement in Type II diabetic patients. Diabetologia 44:2092-2097. (Pubitemid 33124056)
41. Wallace TM, Matthews DR. 2002. The assessment of insulin resistance in man. Diabet Med 19:527-534.
42. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM. Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta B, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161-169. (Pubitemid 351171403)
43. Williams JC, Barratt-Boyes BG, Lowe JB. 1961. Supravalvular aortic stenosis. Circulation 24: 1311-1318.
44. Yeckel CW,Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S. 2004. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89:1096-1101. (Pubitemid 38368396)